---
title: "valproic acid - migraine"
sidebar: mydoc_sidebar
permalink: valproicacidmigraine2.html
toc: false 
---

{% include image.html file="valproicacidmigraine2.png" alt="valproicacidmigraine2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014635 | valproic acid | Drug |
| UniProt:O14975 | microsomal long-chain fatty acyl-CoA synthetase | Protein |
| UBERON:0000955 | brain | GrossAnatomicalStructure |
| MESH:C026563 | Arachidonoyl-CoA | ChemicalSubstance |
| REACT:R-HSA-2162123 | inflammatory prostaglandins production | Pathway |
| MESH:D008881 | migraine | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Valproic Acid | DECREASES ACTIVITY OF | Microsomal Long-Chain Fatty Acyl-Coa Synthetase |
| Microsomal Long-Chain Fatty Acyl-Coa Synthetase | LOCATED IN | Brain |
| Brain | DECREASES ABUNDANCE OF | Arachidonoyl-Coa |
| Arachidonoyl-Coa | PARTICIPATES IN | Inflammatory Prostaglandins Production |
| Inflammatory Prostaglandins Production | PREVENTS | Migraine |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00313#mechanism-of-action](https://go.drugbank.com/drugs/DB00313#mechanism-of-action){:target="_blank"}